Leveraging AI in Healthcare and Life Sciences Discussion: Join our CEO, Colin Hill at the Sixth Annual International IP Summit
We are delighted to announce that Aitia will be participating in the Sixth Annual International IP Summit. Our CEO, Colin Hill, will be a featured speaker at an engaging discussion titled: Leveraging AI in Healthcare and Life Sciences: Key Legal Considerations. Colin will be joined by industry experts Dr. Bernardo Bizzo, the Senior Director of […]
Aitia and Pancreatic Cancer Action Network Partner to Transform De-Identified Multi-Omic Patient Data into Digital Twins to Drive New Discoveries and Improve Patient Outcomes
LOS ANGELES and SOMERVILLE, MA, Sept 27, 2023: Aitia, the leader in the development and application of Causal AI and Digital Twins to discover and develop new drugs, today announced a collaboration with the Pancreatic Cancer Action Network (PanCAN), a leading nonprofit in the fight against pancreatic cancer. This strategic collaboration marks a significant milestone for Aitia, […]
A Digital Boost for Pharmaceutical R&D: Join our CEO, Colin Hill at the Orion Day in Finland
We are thrilled to announce that Aitia will be participating at the Orion Day conference. Our CEO, Colin Hill, will be giving a keynote titled: AI-Powered Digital Twins: Revolutionizing Pharmaceutical Drug Discovery and Clinical Development to Create the Next Generation of Breakthrough Drugs. During the keynote, Colin will share valuable insights and engage in a dynamic […]
Accelerating Drug Target Identification and Validation with AI and Digital Twins: Join our CBO, Joseph Donahue at BioTechX Europe 2023
We are thrilled to announce that Aitia will be participating in Basel at the BioTechX Europe 2023 conference. Our CBO, Joseph Donahue, will be taking the stage in the AI in Drug Development and Discovery session to talk about Aitia’s commitment in accelerating AI-driven discoveries and share valuable insights on harnessing Causal AI and Digital […]
CEO and Investor Roundtable Discussion: Join our CEO, Colin Hill at BioCentury East-West Pharma Summit 2023
We are delighted to announce that Aitia will be participating in the prestigious global East-West Pharma Summit 2023 conference. Our CEO, Colin Hill, will be a featured speaker at a roundtable discussion along with industry experts Christine Aylward, the Founding & Managing Partner of Magnetic Ventures, Nathalie Beslay, the Co-founder of NAAIA, Michelle Chen, PH.D., […]
Webinar | From the beta-amyloid hypothesis to AI-driven discoveries of novel biomarkers and breakthrough drugs in Alzheimer’s Disease
Alzheimer’s disease research has taken center stage in the world of drug discovery and clinical development. The convergence of causal AI, supercomputing power, and multi-omic human data is allowing us to begin to unravel the molecular circuity of this debilitating disease in order to discover the next generation of breakthrough drugs and predictive biomarkers. In […]
Aitia Appoints Drug R&D Executive Jean-Michel Gries as President & Chief Operating Officer
Somerville, MA, Sept 19, 2023: Aitia, the leader in the development and application of Causal AI and Digital Twins to discover and develop new drugs, today announced the appointment of Dr. Jean-Michel Gries as President & Chief Operating Officer. In this role, Jean-Michel will lead the company’s AI-driven drug discovery and development strategy while overseeing […]
Driving Research in Pancreatic Cancer: Join our CEO, Colin Hill on the PanCAN Scientific Summit 2023
We are thrilled to announce that Aitia will be participating in the highly anticipated PanCAN Scientific Summit 2023 conference. Our CEO, Colin Hill, will be taking the stage in the scientific session to talk about Aitia’s commitment in accelerating AI-driven discoveries in pancreatic cancer and share valuable insights on harnessing AI technology and Digital Twins […]
Fireside Chat: Join our CEO, Colin Hill on the Longwood Healthcare Leaders Fall Conference
We are delighted to announce that Aitia will be participating in the industry-leading Longwood Healthcare Leaders Fall Conference. Our CEO, Colin Hill, will moderate a Fireside Chat with industry experts Dave Reese, EVP R&D at Amgen and Priya Singhal, EVP & Head, Development & Interim Head of Research at Biogen. The conference focuses on a […]
Webinar | From the beta-amyloid hypothesis to AI-driven discoveries of novel biomarkers and breakthrough drugs in Alzheimer’s Disease
We are delighted to announce our upcoming webinar on Thursday, September 14, 10:00 am ET. From the beta-amyloid hypothesis to AI-driven discoveries of novel biomarkers and breakthrough drugs in Alzheimer’s Disease. Alzheimer’s disease research has taken center stage in the world of drug discovery and clinical development. The convergence of causal AI, supercomputing power, and multi-omic […]